News and Events
Here you will find current and archived press releases, listings of upcoming events, and news coverage about the company and some of its projects and initiatives.
13 January 2023
Growth supported by the high-throughput genomic sequencing laboratory in Evry Continued sequencing activities on platforms operated on behalf of third parties supported by new clinical research projects in oncology EVRY, FRANCE, FRIDAY JANUARY 13TH 2023, 7.30AM CET – IntegraGen (FR0010908723 – ALINT), an OncoDNA Group company specializing in the decryption of (…) »
18 October 2022
Better profitability despite the inflation Confirmed growth outlook for the 2022 financial year Increase in services provided to platforms operated on behalf of third parties EVRY, FRANCE, TUESDAY OCTOBER 18TH 2022, 7.30AM – IntegraGen (FR0010908723 – ALINT – Eligible PEA PME), IntegraGen, a company specializing in the decryption (…) »
13 July 2022
Continued sustained growth associated with the company’s sequencing platform in Évry and long-term contracts Strong revenue growth linked with microbiology sequencing
Evry, France, Wednesday July 13th 2022, 7.30am – IntegraGen (FR0010908723 – ALINT ), an OncoDNA Group company specializing in the decryption of the human genome which performs (…) »
29 April 2022
Positive EBITDA and net result Large increase in services delivered for the SeqOIA GCS and the P2M platform operated for Institut Pasteur Limited negative impact from the pandemic along the year Outlook: continued revenues growth for 2022 based on orders book
Évry, France, april 29TH 2022 – 6.00pm (…) »
20 January 2022
IntegraGen and BIOASTER have been collaborating for several years in the context of genomic and transcriptomic analyses. Driven by a desire to strengthen this relationship further, the two entities have entered into a long-term partnership agreement (Master Research Service Agreement). This agreement will facilitate and accelerate exchanges between (…) »
19 January 2022
Rejoignez-nous lors du 33ème séminaire de génétique clinique les 2 et 3 février 2023 à Angers. Thomas Bolzec et Mira Ayadi vous attendent avec plaisir sur notre stand pour discuter de vos projets de génomique. N’hésitez pas à les contacter pour prendre rendez-vous : services@integragen.com
14 January 2022
Significant increase in services delivered by SeqOIA and the Mutualized Microbiology (P2M) platform operated on behalf of the Institut Pasteur Stability of sequencing services provided by the Evry laboratory
EVRY, FRANCE, FRIDAY 14 JANUARY 2021, 7.30 – IntegraGen (FR0010908723 – ALINT – Eligible PEA PME), an OncoDNA group (…) »
24 December 2021
Ditsa Keren is a technology blogger and entrepreneur with a strong passion for biology, ecology and the environment. She spoke to our CEO Bernard Courtieu to hear about the latest advancements in precision medicine and the promise we bring to oncology physicians and researchers.
Discover the entire interview on (…) »
24 September 2021
OncoXPLORE, a comprehensive cancer gene panel test for the exploration of solid tumors
On the occasion of the World Cancer Research Day, OncoDNA proudly announces the launch of its latest genomic solution for cancer research, OncoXPLORE. OncoDNA has long been a strong supporter of cancer research. Through a (…) »
16 July 2021
A Powerful Workflow to Access Cancer Gene Expression Signatures
In additional to DNA sequencing, RNA sequencing can provide researchers and clinicians with additional insights into tumor tissues. The technology offers the opportunity to explore the gene expression profiles and the states of tumor cells in real time.
(…) »
